FDA to Hear Appeal on Breast Cancer Drug (HealthDay)

Admin

Administrator
Staff member
HealthDay - TUESDAY, June 28 (HealthDay News) -- The controversial cancer drug Avastin becomes the focus of U.S. regulators' attention again Tuesday during a two-day hearing to determine if the medication can keep its FDA approval for the treatment of metastatic breast cancer.

More...
 
Top